Infection risk test in intensive care patients
Treatments studied
This study looks at how the body's immune system responds to severe injury or illness by measuring a substance called interferon-gamma (IFN-γ) in the blood. The goal is to better understand infection risk and help doctors improve care for patients in the intensive care unit (ICU).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Admitted to intensive care after a bad injury (trauma), severe breathing problems, or major heart, blood vessel, or stomach surgery that needs ICU stay
- Not pregnant
- Hemoglobin (a part of your blood that carries oxygen) level is 7 g/dL or higher
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system responds while you’re in the intensive care unit (ICU) for COVID-19. Researchers will collect samples early in the ICU stay to better understand immune changes during the illness.
This study looks at how your immune system and inflammation affect your recovery in the intensive care unit. Researchers want to understand why some patients do better than others.
This trial tests if a drug called interferon gamma can help prevent new infections in ICU patients with a weakened immune system. It may help people who have been in the ICU for at least a week and have had multiple organ failure.
This trial tests if a drug called interferon gamma can help boost the immune system of patients in the ICU who are fighting serious infections. It is for adults who are on a breathing machine and have low immune function.
This study looks at how having a weakened immune system affects the risk of getting infections with hard-to-treat bacteria in the ICU. Depending on your immune status, you may be placed in a group that helps doctors understand who is most at risk.
This study wants to learn how your immune system reacts to a serious infection (like sepsis) in the ICU. By looking at your immune cells, doctors hope to better predict your recovery and find the best treatment for you.
Hear when a new Intensive Care trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.